NCT04504474

Brief Summary

The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 21, 2018

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2021

Completed
Last Updated

August 7, 2020

Status Verified

August 1, 2020

Enrollment Period

3.1 years

First QC Date

August 5, 2020

Last Update Submit

August 5, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Co-morbidity

    Characterize the ADHD/MDD symptom network in a psychiatric outpatient setting comprised of adults

    September 8, 2021

  • Network reliability

    Determine the stability and reliability of this network

    September 8, 2021

  • Central symptoms

    Determine the central symptoms that lead to co-activation of ADHD/MDD clusters

    September 8, 2021

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

We will gather a recruitment of 500 male and female outpatients from the Psychiatric Outpatient Clinic at Kirkwood Site attached to Health Sciences North.

You may qualify if:

  • participants have a diagnosis of MDD or ADHD or both
  • participants are competent to consent to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kirkwood Site - Health Sciences North

Greater Sudbury, Ontario, P3E 1X3, Canada

RECRUITING

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Kuppuswami Shivakumar, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2020

First Posted

August 7, 2020

Study Start

June 21, 2018

Primary Completion

August 8, 2021

Study Completion

September 8, 2021

Last Updated

August 7, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

None of the IPD will be shared with other researchers

Locations